NuvOx drug that aids radiation treatments set for clinical trials

NuvOx Pharma is planning a phase II clinical trial for an injectable drug that can infuse tumors with oxygen to make them more susceptible to radiation treatment.

Read more: NuvOx Pharma set for Clinical Trials